Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för CHIR-98014. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

10 träffar

Bibliografisk träff 2021-03-02

Multi-omics characterization of WNT pathway reactivation to ameliorate BET inhibitor resistance in liver cancer cells.

Liu Y, Xue M, Cao D, Qin L, Wang Y, Miao Z, Wang P, Hu X, Shen J, Xiong B.

Genomics · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ygeno.2021.02.017

Bibliografisk träff 2020-03-31

The apoptotic effect of GSK-3 inhibitors: BIO and CHIR 98014 on H1975 lung cancer cells through ROS generation and mitochondrial dysfunction.

Mathuram TL, Venkatesan T, Das J, Natarajan U, Rathinavelu A.

Biotechnol Lett · journal article · DOI 10.1007/s10529-020-02861-w

Bibliografisk träff 2019-10-10

GSK-3 modulates SHH-driven proliferation in postnatal cerebellar neurogenesis and medulloblastoma.

Ocasio JK, Bates RDP, Rapp CD, Gershon TR.

Development · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1242/dev.177550

Bibliografisk träff 2018-12-15

Tuft1 promotes thyroid carcinoma cell invasion and proliferation and suppresses apoptosis through the Akt-mTOR/GSK3β signaling pathway.

Liu H, Zhu J, Mao Z, Zhang G, Hu X, Chen F.

Am J Transl Res · research-article; journal article

Bibliografisk träff 2018-05-26

The Alzheimer's disease-associated TREM2 gene is regulated by p53 tumor suppressor protein.

Zajkowicz A, Gdowicz-Kłosok A, Krześniak M, Janus P, Łasut B, Rusin M.

Neurosci Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.neulet.2018.05.037

Bibliografisk träff 2018-02-08

LMO3 promotes gastric cancer cell invasion and proliferation through Akt-mTOR and Akt-GSK3β signaling.

Qiu YS, Jiang NN, Zhou Y, Yu KY, Gong HY, Liao GJ.

Int J Mol Med · research-article; journal article · DOI 10.3892/ijmm.2018.3476

Bibliografisk träff 2017-10-10

Synthesis, Binding Mode, and Antihyperglycemic Activity of Potent and Selective (5-Imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine Inhibitors of Glycogen Synthase Kinase 3.

Wagman AS, Boyce RS, Brown SP, Fang E, Goff D, Jansen JM, Le VP, Levine BH, Ng SC, Ni ZJ, Nuss JM, Pfister KB, Ramurthy S, Renhowe PA, Ring DB, Shu W, Subramanian S, Zhou XA, Shafer CM, Harrison SD, Johnson KW, Bussiere DE.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.jmedchem.7b00922

Bibliografisk träff 2015-07-03

Stabilization of microtubular cytoskeleton protects neurons from toxicity of N-terminal fragment of cytosolic prion protein.

Zajkowski T, Nieznanska H, Nieznanski K.

Biochim Biophys Acta · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bbamcr.2015.07.002

Bibliografisk träff 2014-04-29

Cytotoxicity and activation of the Wnt/beta-catenin pathway in mouse embryonic stem cells treated with four GSK3 inhibitors.

Naujok O, Lentes J, Diekmann U, Davenport C, Lenzen S.

BMC Res Notes · research support, non-u.s. gov't; research-article; journal article · DOI 10.1186/1756-0500-7-273

Bibliografisk träff 2003-03-01

Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo.

Ring DB, Johnson KW, Henriksen EJ, Nuss JM, Goff D, Kinnick TR, Ma ST, Reeder JW, Samuels I, Slabiak T, Wagman AS, Hammond ME, Harrison SD.

Diabetes · research support, non-u.s. gov't; journal article · DOI 10.2337/diabetes.52.3.588